Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Product
Deals
Articles
BioCentury
|
Apr 5, 2010
Finance
2Q Financial Markets Preview: Wanted Dry Powder
...Dutogliptin (PHX1149) Type II diabetes Ph III data 2Q10 China Aoxing Pharmaceutical Co. Inc. (OTCBB:CAXG)
Tilidine hydrochloride
...
Read More
BioCentury
|
Feb 1, 2010
Clinical News
Tilidine hydrochloride: Phase III completed
...mg morphine sulfate in 200 patients. China Aoxing Pharmaceutical Co. Inc. (OTCBB:CAXG), Shijiazhuang, China Product:
Tilidine hydrochloride
...
Read More
BioCentury
|
Feb 1, 2010
Clinical News
Tilidine hydrochloride: Phase III completed
...mg morphine sulfate in 120 patients. China Aoxing Pharmaceutical Co. Inc. (OTCBB:CAXG), Shijiazhuang, China Product:
Tilidine hydrochloride
...
Read More
BioCentury
|
Apr 23, 2007
Clinical News
Tilidine hydrochloride: Phase III start
...tilidine in China next year. China Aoxing Pharmaceutical Co. Inc. (CAXG), Jersey City, N.J. Product:
Tilidine hydrochloride
...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page